Hantaviruses are a newly zoonotic emerging group of rodent-borne viruses that have a significant impact on global public health by increasing amplitude and magnitude of outbreaks. As no permanent cure yet, it is now growing and challenging interest to develop a vaccine against Hantavirus. This study endeavored to design a robust subunit vaccine using a novel immunoinformatics approach. After meticulous evaluation, top ones from predicted CTL, HTL, and B-cell epitopes were considered as potential vaccine candidates. Among generated four vaccine models with different adjuvant, the model with TLR-4 agonist adjuvant was selected for its high antigenicity, non-allergenicity, and structural quality. The conformational B-cell epitope prediction assured its humoral response inducing ability. Thereafter, the molecular docking and dynamics simulation confirmed a good binding affinity with immune receptor TLR-4 and stability of the vaccine-receptor complex. In immune simulation, significantly high levels of IgM and IgG1 immunoglobulins, TC and TH-cell populations, and various cytokines (i.e. IFN-γ, IL-2 etc.) are coherence with actual immune response and also showed faster antigen clearance for repeated exposures. Finally, disulfide engineering enhanced vaccine stability and in silico cloning confirmed the better expression in E. coli K12. Nonetheless, experimental validation can proof the proposed vaccine's safety and ability to control Hantavirus infection.
with respiratory failure and cardiogenic shock 9 . However, against this severely emerging virus, there are only some inactivated vaccines have been developed from Hantavirus in cell cultures or the rodent brain, and a few of these have been licensed for humans in Korea and China 35 .
The immune response plays an important role in the pathogenesis of Hantavirus infection 3 and conversely plays a critical role in fighting tumors and viral infections 39 . In modern times, immunotherapy is a powerful and efficient strategy for the prevention of infectious diseases. Recently, the multi-epitope vaccine is an ideal approach for the prevention and treatment of tumors or viral infections [40] [41] [42] [43] [44] . There are many multi-epitope vaccine design studies involving various viruses like HIV 45 , Dengue virus 46 , Hepatitis B virus 47 , Hepatitis C virus 48, 49 , Ebola virus 50 , Chikungunya virus 51 , Avian influenza A (H7N9) virus 52 , Zika virus 53 , Classical swine fever virus 54 , Nipah virus 55 , and Norovirus 56 . An ideal multi-epitope vaccine should be designed to include a series of or overlapping epitopes so that its every basic unit called antigenic peptide fragment can elicit either a cellular or a humoral immune response against the targeted tumor or virus 39 . In present, the multi-epitope vaccine approach has fascinated more global attention over traditional or single-epitope vaccine as it has a unique design mechanism with some properties 39 : (a) consist of multiple MHC-restricted that can be recognized by TCRs of multiple clones from various T-cell subsets; (b) consist of TC, TH, and B-cell epitopes that can induce strong cellular and humoral immune response simultaneously; (c) consist of multiple epitopes from different tumor/virus antigens that can expand the spectra of targeted tumors or viruses; (d) introduce some components with adjuvant capacity that can enhance the immunogenicity and long-lasting immune responses; and (e) reduce unwanted components that can trigger either pathological immune responses or adverse effects. A welldesigned multi-epitope vaccine should become a powerful prophylactic and therapeutic agent against the targeted tumor or virus. In this study, a series of immunoinformatics approaches have been applied on the whole proteome of Hantavirus for developing a multi-epitope vaccine using the screened robust TC, TH, and B-cell vaccine candidates. Furthermore, the developed vaccine was studied for its antigenicity and allergenicity and subsequently the structural prediction was done. Moreover, the codon adaptation and in silico cloning, disulfide engineering, binding affinity with the immune receptor, and the molecular dynamics simulation of the best vaccine-receptor docked complex were sequentially studied. The in silico immune simulation has also been performed.
Results and discussion

Representative Proteins Selection of Orthohantavirus
In order to design a candidate vaccine, the total of 2487 protein sequences of 112 organisms of orthohantavirus was retrieved from the NIAID Virus Pathogen Database and Analysis Resource (ViPR) in a single FASTA file; where 68 organisms with 2162 proteins are classified and the remaining 44 organisms with 325 proteins are unclassified. The data overview is illustrated in Fig. 1 after rearranging the retrieved sequences according to their category, organism, and epidemic nature. 
Prediction of Linear B-Lymphocyte Vaccine Candidates
The selected highest antigenic 11 proteins were submitted to the LBtope server and a total of 2939 epitopes were predicted. The predicted epitopes were considered for the evaluation of their antigenicity, conservancy, and toxicity. According to the antigenicity≥0.4 and non-toxin criteria, only 1789 epitopes have remained and were taken into account for investigating their allergenicity and found that 1011 epitopes have non-allergic nature. Subsequently, among the nonallergic epitopes, from each protein the best one epitope was selected as a vaccine candidate that significantly satisfies all the characteristics than other epitopes of that protein (Tab. 3). Fig. 2(a) ). Herein, we mentioned 16 different geographical areas capturing the world where the maximum percentage of cumulative population coverage in Europe (99.10%), nearly followed by East Asia (98.72%), North America (98.43%), and others ( Fig. 2(b) ). The 97.94% population of the world covered by predicted vaccine candidates ( Fig. 2(b) ). The population coverage analysis revealed that the MHC HLA alleles corresponding to predicted T-cell vaccine candidates are well & widely distributed throughout the world, which is a robust property of rational vaccine design 57, 58 .
Molecular Docking Analysis of MHC HLA Alleles-Peptides Interactions
The binding ability of the predicted vaccine candidates with their associated MHC HLA alleles should be checked for their robustness. To do this, the predicted vaccine candidates were modeled through PEPFOLD v3.5 and their associated lowest percentile ranked allele proteins were downloaded from PDB. At first, the control score of the allele proteins with their experimental ligand was examined. Thereafter, the molecular dockings of the peptide-allele complexes were done through AutoDock & AutoDock Vina and the docking scores were compared with their control scores (Fig. 3 ). The vaccine candidates exhibited good binding energy with their respective HLA-alleles. The epitope-allele docked complexes were shown in Fig. 4 . 
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Cluster Analysis of the MHC Restricted HLA Alleles
The MHCcluster v2.0 generated a correlation heat-map for clustering both the MHC-I and MHC-II HLA molecules interacted with the predicted robust vaccine candidates. The generated heat-map is illustrated in Fig. 5 showing a satisfactory functional relationship among detected allele molecules as the red-colored zones indicating strong correlation and gradually yellow-colored zones indicating weaker correlation 59 .
Multi-Epitope Subunit Vaccine Protein Construction
The immune response plays a critical role in fighting viral infections and its molecular and cellular mechanisms induced by the multi-epitope vaccine 39 . Therefore, extracted robust vaccine candidates of total 11 CTL, 11 HTL, and 11 BL epitopes were sequentially fused together with the help of suitable linkers for the long chain of multi-epitope vaccine protein. The linkers GGGS, GPGPG, and KK were used to connect the intra-CTL, intra-HTL, and intra-BL epitopes, respectively. A multi-epitope subunit vaccine must contain a strong immunostimulatory adjuvant for enhancing the immunogenicity and activating long-lasting innate and adaptive immune response 39, 60 . Four vaccine models of length 654, 692, 686, and 777 amino acids were designed by adding TLR4 agonist, β3-defensin, β3defensin with RR residues, and 50S ribosomal protein L7/L12 at the N-terminal site of the vaccine protein using EAAAK linker, respectively. The lengths of the designed vaccine models are not too long comparing to the other developed multi-epitope vaccine against Fasciola gigantic, Schistosoma mansoni and Onchocerca volvulus of length 765, 617 and 599, respectively [61] [62] [63] . Shanmugam et al. reported that synthetic TLR4 can be used as a novel adjuvant 64 . The βdefensin can recruit the Naïve T-cell and immature dendritic cells (DC) at the site of infection through the CCR6 receptor and it can also provide an adaptive immune response and innate host response in microbial infection 65 . The 50S ribosomal protein L7/L12 act as an immunoadjuvant for dendritic-cell (DC) based immunotherapy and it is capable of inducing DC maturation 66 . The schematic diagram of the vaccine construct is represented in Fig. 6 . 
Immunological Comparison of Vaccine Models
Immunological properties such as antigenicity and allergenicity were evaluated for all vaccine models and the results were illustrated in Fig. 7 (a). The high antigenicity indicates the better ability to induce an immune response. As the allergy involves a series of complex reactions by the immune system due to the foreign antigenic substance and results in sneezing, wheezing, skin rash, and swelling of the mucous membrane, the non-allergic vaccine is safe for human life 67 . All the vaccine models showed antigenic and non-allergic in nature. The vaccine model-1 was characterized by higher antigenicity of 0.9876 but the higher nonallergen score of -0.917 was assigned to the vaccine model-3. 
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Structural Comparison of Vaccine Models
The secondary structural features of the vaccine models were assessed from SOPMA server using their amino acid sequences. The predicted results were illustrated in Fig. 7(a) . Thereafter, the vaccine models were submitted to RaptorX server for predicting their 3D structures. The predicted results were checked for the gap between domains of the predicted 3D models and observed that only the vaccine model-1 exhibited no gap between domains ( Fig. 7(a) ). The 3D protein models having a gap between domains create problems in the refining stage of those models 68 . Therefore, the vaccine model-1 was selected as the final vaccine construct for further immunoinformatics approaches. A probability score graph of occurrence of helix, strand, turn, and coil at each amino acid position in the secondary structure of the final vaccine construct is shown in Fig. 8(a) . The tertiary structure of the final vaccine construct was predicted as 2 domains (5j81:A, 4ind:A) and modeled using 4ind:A as the best template with a score of 50. All of the 654 amino acids were modeled, but 10% of residues were predicted as disordered. The p-value and uGDT value are the quality measures in homology modeling, lower p-value and higher uGDT value confirm the quality of the modeled structure 69 . The p-value and uGDT values obtained for the modeled structure were 8.84×10 -5 and 120, respectively, which are sufficiently low and large, respectively. 
Refinement and Quality Assessment of the Tertiary Structure of the Final Vaccine Construct
Structural refinement with GalaxyRefine can improve the structural quality by increasing the number of residues in the favored region. GalaxyRefine provided five models with various quality assessment parameters (Tab. S2). Among them, the model 4 was taken into consideration as the best 3D structure of the final vaccine construct for further analysis according to various quality parameters including GDT-HA (0.9209), RMSD (0.502), MolProbity (2.432), Clash score (28.6), Poor rotamers (0.8), and Rama favored (91.9). For the structural validation of the refined model, the Ramachandran plot analysis was done and found that 86.2%, 11.3%, 1.0%, and 1.3% residues in Rama-favored regions, additional allowed regions, generously allowed regions, and disallowed regions, respectively ( Fig.  8(b) ). The overall quality and potential errors in a crude 3D model were verified through ERRAT and ProSA-web server. The overall quality factor of the refined model was 52.13% using ERRAT. While ProSA-web has shown the Z-score of -3.51 of the refined model which is out of range that commonly found in the case of native proteins for comparable size but it is supported by experimentally validated structures and close to the database average ( Fig. 8(c) ) 70 . The refined 3D model is illustrated in Fig. 8(d) . 
Assessment of Primary Sequence Features of the Final Vaccine Construct
The various primary sequence features of the final vaccine construct were evaluated through ExPASy ProtParam server ( Fig. 7(b) ). The molecular weight of the final vaccine construct was found to be 70.5 kDa which is the indication of good antigenic nature of the final vaccine construct 70 . The proteins having <110 kD molecular weight are believed to be good vaccine candidates 71 . The theoretical isoelectric point (pI) is valuable to provide a buffer system for vaccine purification which was computed to be 10 showing slightly basic in nature of the construct. Moreover, the estimated half-life was found to be 1 hour in mammalian reticulocytes, in vitro; while 30 minutes in yeast and >10 hours in E. coli, in vivo. The instability index was assessed to be 32.04 which represents the stable nature of the final vaccine construct 72 . The score of the aliphatic index was 76.22 which is the indication of the thermostable nature of the final vaccine construct; the higher aliphatic index is associated with more thermostability 60 . The estimated grand average of hydropathicity (GRAVY) value was calculated as -0.255, negative GRAVY value declared the final vaccine construct is hydrophilic in nature and it has good interaction with a water molecule 60 . 
Mapping of Conformational B-cell Epitopes in Final Vaccine Construct
B-cells are the key player of humoral immunity and epitope corresponding to the B-cell receptor plays an important role in vaccine design following antibody production 60 . The discontinuous B-cell epitopes were searched in the final vaccine construct using the IEDB ElliPro tool and found 10 significant discontinuous B-cell epitopes with length range 4-110 and score range 0.557-0.811 (Tab. S3). The structural view of those epitopes was illustrated in Fig. 9 .
Molecular Docking of Final Vaccine Construct with TLR4 Immune Receptor
The vaccine-receptor docking was performed through ClusPro v2.0 for assessing the binding affinity of the vaccine construct with the immune receptor TLR4 and the ClusPro 2.0 server predicted a total of 26 complex forms (Tab. S4). Among them, the model having the lowest energy score properly occupied the receptor 73 and found that the model number 11 was selected as the best-docked complex (Fig. 10) . The energy score of the best-docked complex was found to be -1292 which is the lowest among all other predicted complexes showing the highest binding interaction. 
In Silico Cloning of the Final Vaccine Construct
To express the deigned vaccine protein into the E. coli expression system, in silico cloning was done. Therefore, it was necessary to adapt the codon respective to the vaccine constructs as per the codon usage of E. coli expression system. The adaptation of the codon usage of vaccine construct as per E. coli K12 was done using the JCat server. The JCat provided the optimized codon sequence of 1962 nucleotides, whose codon adaptive index (CAI) and percentage of the GC-content codon were found to be 0.98 and the percentage of the GC-content codon of 53.77%. The CAI value is very close to the best score 1.0 and the percentage of the GC-content codon lying in the allowed range 30-70%, therefore, both of them ensured the high expression rate of vaccine construct in E. coli K12 46 . Later on, the adapted codon sequence was inserted into the E. coli pET28a(+) vector and obtained a cloned vaccine of 7258 base pairs (Fig. 11 ). 
Disulfide Engineering of the Final Vaccine Construct
To stabilize the constructed vaccine structure, disulfide engineering was done through Disulfide by Design 2 (DbD2), and a total of 70 pairs of residues were predicted for the probable formation of disulfide bonds (Tab. S5). However, only 5 pairs of residues (Gly344-Ile507, Arg184-Pro265, Thr401-Gly436, Tyr413-Glu556, and Ala270-Pro375) were selected for the disulfide bond formation because their energy and Chi3 values lies within the allowed range i.e. the energy score should be less than 2.2 and the Chi3 value should be in between -87 to +97 74 . Thereafter, the stability of the vaccine structure for the mutation of every residue by cysteine in the selected 5 pairs was evaluated through DynaMut server and found that only three mutations of Gly344, Thr401, & Gly436 residues have positive vibrational entropy changes, which indicates the stability of the vaccine construct (Tab. S6). Among those three residues, Thr401 and Gly436 fulfill a pair for probable disulfide bond. Therefore, these two residues, Thr401 and Gly436 were taken into account for the mutation with cysteine ( Fig. 12 ).
Figure 10:
The docked complex of the vaccine construct with the TLR4 receptor (cyan color represent the vaccine construct and magenta color represent the TLR4 receptor).
Molecular Dynamics Simulation of the Best Vaccine-Receptor Docked Complex
The stability and large-scale mobility of the best vaccine-receptor docked complex were investigated by performing normal mode analysis (NMA) of its internal coordinates via iMODS. The vaccine protein and the receptor TLR4 were directed towards each other and the direction of each residue was represented by arrows ( Fig. 13) ; where the length of the line indicates the degree of mobility. The vaccine-receptor complex deformability depends on the individual distortion of each residue, indicated by hinges in the high deformability region of the chain (Fig. 14(a) ). The B-factor values inferred via NMA was equivalent to RMS ( Fig. 14(b) ). The complex eigenvalue was found to be 5.608279×10 -06 ( Fig. 14(c) ); where the lower the eigenvalue, the easier the deformation 75 . The eigenvalue is inversely related to the variance of the complex (Fig. 14(d) ) 76 . In the covariance matrix, the red, white, and blue colors indicate the correlated, uncorrelated, and anticorrelated pairs of residues ( Fig. 14(e) ) 75, 77 . An elastic network model was generated to represent the pair of atoms connected via springs ( Fig. 14(f) ). In the elastic graph, each dot represents one spring between the corresponding pair of atoms, where the darker grays indicate stiffer springs and vice versa 75 . Figure 11 : Cloned multi-epitope vaccine construct. In silico cloning of the adapted codon sequence of the final vaccine construct (red-green color) into the E. coli pET28a(+) vector (blue-magenta color).
In Silico Immune Simulation of Final Vaccine Construct
The in silico immune response of the vaccine construct was generated by C-ImmSim immune simulator. The immune simulation showed results consistent with the typical immune response (Fig. 15 ). The primary response was identified by high levels of IgM. Following the secondary and tertiary responses were characterized by the high level of IgG1 + IgG2, IgM, and IgG + IgM antibodies with a corresponding decrease in antigen concentration ( Fig. 15(a) ). Furthermore, several long-lasting B-cell isotypes were observed, indicating possible isotype switching potentials and memory formation ( Fig. 15(b-c) ). A similarly high response was highlighted in the TH (helper) and TC (cytotoxic) cell populations with respective memory development ( Fig. 15(d-g) ). During exposure, increased macrophage activity was demonstrated while dendritic cell activity was identified as consistent ( Fig. 15(h-i) ). The macrophages and dendritic cells are important when the expression of TLR4 in human is considered 78 . High levels of IFN-γ and IL-2 were also evident and the lower the Simpson index (D), the greater the diversity (Fig. 15(j) ) 79 . The high level of IFN-γ and IL-2 production confirms the efficient Ig production, thereby, supporting a humoral response 63 . In addition, there are many other characteristics have been produced such as PLB cell population, TR cell population per state, NK cell population, and EP population per state (Fig. S1) ; where all of them showed excellent immune response. This profile indicates the immune memory development and consequently the increased clearance of the antigen at subsequent exposures.
Conclusion
The Zoonotic Hantavirus infection has emerged as a globally severe life-threatening problem characterized by an increasing number of infections and followed by deaths by 50%, worldwide. Despite this, there is no permanent cure or preventive treatment against Hantavirus is currently available. Therefore, it is urgent to explore an effective vaccine against Hantavirus to fight this severe problem. This study harnessed a complete series of immunoinformatics approaches to develop a novel multiepitope subunit vaccine containing T & B-cell epitopes for inducing cellular and humoral immunity, respectively. The T & B-cell epitopes were predicted from the selected highly antigenic proteins of every gene product. The predicted epitopes were filtered by antigenicity≥0.4 & immunogenicity>0 and followed by filtering by the non-toxin & non-allergic criterions. In addition, the helper T-cell epitopes were over-filtered by IL-10 & IFN-γ inducing criterions. Furthermore, the top conservancy associated epitope from every gene product was selected as potential vaccine candidate; among those the T-cell vaccine candidates along with their HLA alleles were subjected to analysis of the population coverage in both the epidemic and non-epidemic regions. Thereafter, the potential vaccine candidates were fused together with the help of suitable linkers for their adequate separate functions in the human body. Subsequently, four vaccine models were generated by adding four different adjuvants to the nascent vaccine protein to increase the vaccine immunogenicity. The vaccine models were tested and compared for its antigenicity and allergenicity and followed by the structural analysis. Further, the physicochemical parameters of the final vaccine protein were evaluated and followed by the discontinuous B-cell epitope prediction. Molecular docking and dynamics simulation were also performed to investigate the binding affinity with immune receptor TLR-4 and stability of the vaccine-receptor complex, respectively and followed by conducting immune simulation to ensure the immune response and antigen clearance rate. At last, the disulfide engineering was performed to enhance the vaccine stability and followed by the in silico cloning to confirm the effective expression of the vaccine construct. However, this recommended vaccine requires experimental validation to ensure that it can induce immunity against Hantavirus.
Methodology
Retrieval of Whole Proteome, Grouping, and Assurance of Highest Antigenic Protein of Orthohantavirus
In order to design the subunit vaccine, the whole proteome of the Orthohantavirus was identified and found to be three gene products such as nucleoprotein, envelope glycoprotein (Gn, and Gcformerly known as G1, and G2, respectively), and RNA dependent RNA polymerase (RdRp) protein 9 . The complete amino acid sequences of those proteins were retrieved from the NIAID Virus Pathogen Database and Analysis Resource (ViPR) 80 through the web site at www.viprbrc.org. The retrieved protein sequences were then grouped according to their strain, protein category, and epidemic nature. Thereafter the protein sequences of the targeted groups were subjected to the VaxiJen v2.0 server 81 available at http://www.ddg-pharmfac.net/vaxijen/VaxiJen/VaxiJen.html for predicting their antigenicity and ensuring the highest antigenic proteins for the final dataset preparation, where the threshold parameter was fixed as default.
Prediction of Cytotoxic and Helper T-cell Epitopes with Corresponding Major Histocompatibility Complex Alleles and B-cell Epitopes
The cytotoxic T lymphocytes or CTLs or CD8+ T-cells are essential for immune defense against intracellular pathogens, including virus, bacteria, and tumour surveillance. Therefore, the highly antigenic proteins were submitted to the NetCTL v1.2 82 server available at http://www.cbs.dtu.dk/services/NetCTL/ for predicting CD8+ T-cell epitopes. In the NetCTL server, we predicted the epitopes for 12 supertypes with a combined threshold score of 0.5. Furthermore, the IEDB MHC I Binding tool available at http://tools.iedb.org/mhci/ was used to predict the MHC-I binding alleles corresponding to each CD8+ T-cell epitopes 83 ; where the parameters consensus and human were set as the prediction method and MHC source species, respectively. In addition, the percentile rank≤2 was considered as alleles filtering criteria. On the other hand, the prediction of HTL or CD4+ T-cell epitopes is also a crucial stage of epitope-based vaccine design. The 15-mer CD4+ T-cell epitopes and their corresponding MHC-II binding alleles were predicted through the IEDB MHC II Binding tool (http://tools.iedb.org/mhcii/) using its consensus prediction method 84 . A consensus percentile rank of ≤2 was set as a cutting point for allele selection because a lower percentile rank indicates a more binding affinity. B-cells are considered a core component of the adaptive immune system due to their ability to recognize and provide long-term protection against infectious pathogens by producing antibodies 85 . Therefore, the prediction of B-cell epitopes is important for rational vaccine design. The highly antigenic protein sequences were subjected to the LBtope server (http://crdd.osdd.net/raghava/lbtope/) for predicting the B-cell epitopes 86 . The LBtope predicts the B-cell epitopes based on the support vector machine (SVM) technique (the parameters are LBtope_Fixed, 20-mer peptide, and the percent of probability is 60%).
Screening of CTL, HTL and LBL Epitopes for Potential Vaccine Candidates
The ability of CTL epitopes to trigger humoral and cell-mediated immune response called immunogenicity is the center of the vaccine efficacy 87 . Consequently, the MHC I Immunogenicity tool of IEDB 88 available at http://tools.iedb.org/immunogenicity/ was used to analyze the immunogenicity of CTL epitopes. In the case of subunit vaccination, an epitope is considered to be effective if it has the ability (antigenicity) to induce protection from subsequent challenge by a diseasecausing infective agent in an appropriate animal model following immunization 81 . The epitope-based vaccine containing highly conserved epitopes can provide broader protection across multiple strains or even species 89 . Therefore, the conservancy of the predicted epitopes was analyzed through the IEDB Conservation Across Antigens tool available at http://tools.iedb.org/conservancy/ 89 . Another two important characteristics of peptides such as non-allergenicity and non-toxicity were checked using AllerTOP v2.0 67 and ToxinPred server (http://crdd.osdd.net/raghava/toxinpred/) 90 , respectively. The epitope-based vaccine should be designed to maximize population coverage in any geographical region especially in the region where the associated disease frequently occurs. In contrast, minimizing the number of T-cell epitopes included in the vaccine and the variability of population coverage obtained in different ethnic groups is important to be potential vaccine candidates 91 . Hence, population coverage is a key factor for the development of the peptide-based vaccine 92 . Finally, the IEDB Population Coverage tool 91 (http://tools.iedb.org/population/) was introduced to calculate the population coverage of the T-cell epitopes.
Screening of Cytokine-inducing HTL Epitopes
Several cytokines such as IL-2, IL-6, IL-10, IFN-γ, and TNF-γ are associated with Hantavirus immune system 93 . Herein, due to the tools unavailability, we only predicted the IL-10, and IFN-γ inducer HTL epitopes through the IL-10Pred server (https://webs.iiitd.edu.in/raghava/il10pred/) 94 and IFNepitope server (http://crdd.osdd.net/raghava/ifnepitope/) 95 , respectively in which the SVM technique was chosen as a prediction method. 
Docking Simulation of the MHC HLA Alleles and the Peptide
The predominant binding affinities of the screened epitopes with their corresponding MHC HLA alleles of the known 3D structure were evaluated by the molecular docking simulation 96 . Herein, we used PEPFOLD v3.5 server 97 to predict the tertiary structure of both the screened epitopes and the crystal structures AutoDock tools were used for the preparation of the protein and ligand files into PDBQT files by selecting the binding region and the number of torsion trees, respectively 108 . Finally, these PDBQT files were analyzed by AutoDock Vina software for docking simulation 109 .
Cluster Analysis of the MHC Restricted HLA Alleles
In vaccine development, the resolved MHC super-families (clusters) play an important role for the identification of new targets with optimized affinity and selectivity of hits 110 . The MHC HLA proteins with similar binding affinities were well clustered by the structure-based clustering technique 110 . Herein, the MHCcluster v2.0 available at http://www.cbs.dtu.dk/services/MHCcluster/ was carried out to develop the heat-map of the HLAs functional relationship 59 .
Multi-Epitope Subunit Vaccine Design
An ideal effective multi-epitope vaccine should be composed of epitopes that can elicit CTL, HTL, and B cells and induce effective responses against the targeted virus 39 . The screened CTL, HTL, and LBL vaccine candidates were conjugated in sequential manner to establish the final vaccine construct. In the vaccine construct, the epitopes were separated by proper linkers for their individual effective function 111 . In this study, thelinkers GGGS, GPGPG, and KK were used for the separation of CTL, HTL, and LBL epitopes, respectively. Herein, the immunostimulatory adjuvants TLR4 agonist namely, RS-09, β3-defensin, β3-defensin with RR residues, and 50S ribosomal protein L7/L12 were used as adjuvants to construct four separate vaccine models. The problem of high polymorphic HLA alleles was solved by incorporating the PADRE sequence along with the adjuvants. The EAAAK linker was used to link the adjuvant with the CTL epitope.
Immunological Assessment of the Vaccine Models
The antigenicity is a measure of the ability of an antigen to binds with the B & T-cell receptor that may lead to induce the immune response and memory cell formulation 60 . Accordingly, the whole vaccine construct was submitted to the VaxiJen v2.0 server for predicting the antigenic nature of the vaccine protein.
However, a vaccine with non-allergic behavior will be completely safe for human life 70 . Therefore, the vaccine protein was analyzed for allergenicity using two modules, SVM (amino acid composition) and Hybrid approach under the AlgPred server (https://webs.iiitd.edu.in/raghava/algpred/submission.html) 112 . The allergenicity of the vaccine protein was crosscheck through AllerTOP v2.0, and AllergenFP v1.0 113 .
Secondary and Tertiary Structure Prediction of the Vaccine Models
The whole vaccine constructs were submitted to the Self-Optimized Prediction Method with Alignment (SOPMA) server (https://npsaprabi.ibcp.fr/NPSA/npsa_sopma.html) for predicting the secondary structural features of the vaccine models 114 . As a large portion of the immunoinformatics approach depends on the protein tertiary structure, the three-dimensional structure (3D) prediction is a crucial step for rational vaccine design. Therefore, the tertiary structures of the vaccine models were predicted using the RaptorX server available at http://raptorx.uchicago.edu/ 69 . RaptorX is a multiple-template threading based protein modeling technique, which provides different factors of quality measure such as P-value for relative global quality, GDT & uGDT for absolute global quality, and modeling error at each residue 69 .
Refinement and Quality Assessment of the Tertiary Structure of the Vaccine Construct
The accuracy of the predicted tertiary structure is an important factor for protein docking, function and it depends on the degree of the alikeness of the target and available template structures 46, 115 . Although the template-based protein modeling is more accurate than the template-free protein modeling, but they may still have some problems in local and global structures and the errors such as irregular contacts, clashes, and unusual bond angles & lengths in the predicted 3D models 115 .
Since the inaccuracy in the predicted 3D models also limits the usage of the models for further studies, there was a necessity to improve the accuracy of the predicted model using refinement technique 115 . The refinement of the predicted crude 3D model was done through the GalaxyRefine server (http://galaxy.seoklab.org/cgi-bin/submit.cgi?type=REFINE) 68 . This server works based on a CASP10 tested refinement method which rebuilds the side chains and then repacking the overall structure by molecular dynamics simulation 68 . To validate the accuracy of the refined 3D model, the Ramachandran plot was generated using PROCHECK under the PDBsum server available at www.ebi.ac.uk/pdbsum/ 116, 117 . The refined model also validated by calculating the quality Zscore using the ProSA-web server (https://prosa.services.came.sbg.ac.at/prosa.php) 118 and analyzing the non-bonded interactions using ERRAT server (http://servicesn.mbi.ucla.edu/ERRAT/) 119 . The quality score outside the characteristic range of native proteins indicates possible errors in the predicted 3D structure.
Physicochemical Properties Assessment of the Vaccine Construct
We further characterized the vaccine construct by assessing the various physicochemical properties including molecular weight (MW), theoretical pI, solubility, extinction coefficients (EC), estimated half-life, instability index (II), aliphatic index (AI) and grand average hydropathy (GRAVY) value associated with the vaccine construct. The physicochemical properties excluding solubility were computed by analyzing the vaccine protein sequence through the ProtParam tool under the bioinformatics resource portal Expert Protein Analysis System (ExPASy) (https://web.expasy.org/protparam/) 72 . Later, the solubility of the vaccine protein upon over-expression in E. coli was predicted using the SOLpro tool in the SCRATCH suite 120 .
Conformational B-Cell epitopes Prediction of the Vaccine Construct
The patch of atoms on the protein surface is termed as the discontinuous or conformational epitope. It is predicted to design a molecule that can mimic the structure and immunogenic properties of an epitope and replace it either in the process of antibody production-in this case an epitope mimic can be considered as a prophylactic or therapeutic vaccine-or antibody detection in medical diagnostics or experimental research 121 . Therefore, the CBLs of the vaccine construct were predicted by subjecting the 3D structure of the vaccine construct to the IEDB ElliPro tool available at http://tools.iedb.org/ellipro/ 121 .
Disulfide Engineering of Vaccine Construct
Disulfide bonds can provide increased stability of the protein by reducing unfolded conformational entropy and raising the free energy of the denatured state along with the examination of protein interactions and dynamics 70 . The Disulfide by Design 2 (DbD2) v2.12 server available at http://cptweb.cpt.wayne.edu/DbD2/ was carried out to perform the disulfide engineering of the predicted 3D model of the vaccine construct 74 . The DbD2 can predict the probable pairs of residues that have the characteristics to forma disulfide bond by mutating the individual residues with cysteine. Afterward, the DynaMut server available at http://biosig.unimelb.edu.au/dynamut/ was used to crosscheck the stability of the vaccine construct for the mutation by cysteine of each residue predicted by DbD2
